gennaro daniele
Agostino Gemelli University Polyclinic (IRCCS)
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Associate Editors
thomas daubon
UMR5095 Institut de Biochimie et Génétique Cellulaires (IBGC)
Bordeaux, France
Associate Editor
Cancer Molecular Targets and Therapeutics
ivana de la serna
University of Toledo Medical Center
Toledo, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
ruggero de maria
Catholic University of the Sacred Heart
Milano, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
andre de souza
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
francoise degoul
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Associate Editor
Cancer Molecular Targets and Therapeutics
giuseppe di lorenzo
UNICAMILLUS, INTERNATIONAL UNIVERSITY OF HEALTH SCIENCES
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
nathan dolloff
Medical University of South Carolina
Charleston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
xuesen dong
University of British Columbia
Vancouver, Canada
Associate Editor
Cancer Molecular Targets and Therapeutics
patrycja dubielecka
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
massimo fantini
Precision Biologics, Inc.
Rockville, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
piero ferolla
Mutidisciplinary NET Group, Umbria Regional Cancer Network
Perugia, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
isacco ferrarini
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
elisabetta ferretti
Department of Experimental Medicine, Faculty of Medicine and Dentistry, Sapienza University of Rome
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
soldano ferrone
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
aleksandra filipovic
Imperial College London
London, United Kingdom
Associate Editor
Cancer Molecular Targets and Therapeutics